Link to Webinar
View this webinar, 2016 ATS/CDC/IDSA Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis, which highlights the guidelines development process, the key changes in recommendations and discussion of evidence supporting the changes. This 90-minute presentation is directed toward physicians, nurses and other health professionals who treat and case manage patients with active TB. Sponsored by the five RTMCCs, the presentation was aired on November 4.
Link to Webinar
The 2017 National TB Conference is being held on April 18-21, 2017, at the Atlanta Marriott Marquis in Atlanta, GA, USA.
The National TB Conference welcomes the submission of abstracts for poster presentation on all aspects of tuberculosis control, including epidemiologic, clinical, basic science, nursing, social, behavioral, psychosocial, and educational as well as outcomes of program initiatives. Abstracts are due Tuesday, January 3, 2017 at 11:59 p.m.
The 2017 National TB Conference will kick off with an evening reception and poster discussion session on Tuesday, April 18 from 5:00-6:30 p.m. This session will be held in conjunction with our APHL colleagues.
More Information and Online Abstract Submission Form
The McGill 2017 Summer Institute in Infectious Diseases and Global Health is now open with six courses. Courses include:
You are encouraged to apply early. The deadline for those needing a VISA for Canada is February 28, and registration closes on April 24.
On November 17, 2017, Dr. Zelalem Temesgen of the Mayo Clinic Center for Tuberculosis is giving a presentation on Tuberculosis in the Setting of HIV Infection at the Wisconsin Mycobacteria Laboratory Network (WMLN) Annual Conference. To access the presentation, please click the link below.
Tuberculosis in the Setting of HIV Infection
The CDC Division of Tuberculosis Elimination just released the 2015 surveillance report entitled “Reported Tuberculosis in the United States, 2015” and the accompanying slide set.
These materials and other accompanying communications products will also be made available in a few weeks on the DTBE website at http://www.cdc.gov/tb/statistics/defau
Curry International Tuberculosis Center has published the fully revised and updated third edition of the publication Drug-Resistant Tuberculosis: A Survival Guide for Clinicians. The guide is free and contains information and user-friendly tools and templates for use by any clinician who participates in the management of patients with drug-resistant TB.
To order, click the image below.